These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27127124)

  • 1. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
    Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT
    Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Contribution of Interleukin-10 Promoter Genotypes to Susceptibility to Asthma in Adults.
    Hsia TC; Chang WS; Wang S; Shen TC; Hsiao WY; Liu CJ; Liang SJ; Chen WC; Tu CY; Tsai CW; Hsu CM; Bau DT
    In Vivo; 2015; 29(6):695-9. PubMed ID: 26546526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers.
    Hsia TC; Chang WS; Liang SJ; Chen WC; Tu CY; Chen HJ; Yang MD; Tsai CW; Hsu CM; Tsai CH; Bau DT
    Anticancer Res; 2014 Dec; 34(12):7039-44. PubMed ID: 25503130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.
    Chang WS; Wang SC; Chuang CL; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Liu SP; Hsu PC; Lo YL; Bau DT
    Anticancer Res; 2015 Nov; 35(11):6297-301. PubMed ID: 26504066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
    Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
    Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
    Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
    Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant Association of Interleukin-10 Polymorphisms with Childhood Leukemia Susceptibility in Taiwan.
    Lo WJ; Chang WS; Hsu HF; Ji HX; Hsiao CL; Tsai CW; Yeh SP; Chen CM; Bau DT
    In Vivo; 2016; 30(3):265-9. PubMed ID: 27107085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-10 polymorphisms and smoking on the risk of gastric cancer in Taiwan.
    Kuo WH; Huang CY; Fu CK; Hsieh YH; Liao CH; Hsu CM; Huang YK; Tsai CW; Chang WS; Bau DT
    In Vivo; 2014; 28(5):967-71. PubMed ID: 25189915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.
    Tsai CW; Chang WS; Lin KC; Shih LC; Tsai MH; Hsiao CL; Yang MD; Lin CC; Bau DT
    Anticancer Res; 2014 Jul; 34(7):3731-7. PubMed ID: 24982395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
    Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
    Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Interleukin-10 Genotype to Triple Negative Breast Cancer Risk.
    Chen KY; Chien WC; Liao JM; Tsai CW; Chang WS; Su CH; Hsu SW; Wang HC; Bau DT
    Anticancer Res; 2021 May; 41(5):2451-2457. PubMed ID: 33952470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
    Zhu J; Qin C; Yan F; Wang M; Ding Q; Zhang Z; Yin C
    Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
    Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
    Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
    Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.
    Havranek E; Howell WM; Fussell HM; Whelan JA; Whelan MA; Pandha HS
    J Urol; 2005 Mar; 173(3):709-12. PubMed ID: 15711248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.